Thorsby P M, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen K F, Birkeland K I, Berg J P
Hormone Laboratory, Endocrine Centre, Aker-Ullevål Diabetes Research Centre, Aker University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway.
Scand J Clin Lab Invest. 2009;69(2):282-7. doi: 10.1080/00365510802538188.
We studied the impact of genetic and traditional risk factors for type 2 diabetes in a large, population-based study from Nord-Trøndelag county in Norway (HUNT), in both cross-sectional and prospective design.
65,905 individuals participated in the HUNT study. We studied a randomly selected group of 869 individuals with self-reported diabetes or non-fasting serum glucose >or=11.1 mmol/L and 2,080 non-diabetic control subjects with non-fasting serum glucose <5.5 mmol/L. Four candidate polymorphisms in the three genes TCF7L2 (rs12255372 and rs7903146), PPARG (rs1801282), KCNJ11 (rs5219) and traditional risk factors were studied.
Risk alleles of the TCF7L2 gene showed increased risk of diabetes even when controlled for traditional diabetes risk factors (diabetes in family, waist circumference, physical activity, BMI, SBP and total and HDL-cholesterol) in both a cross-sectional and prospective setting (cross-sectional: rs12255372 OR 1.61 (1.31-1.99), rs7903146 OR 1.48 (1.20-1.83) and prospective: rs12255372 OR 1.59 (1.22-2.07), rs7903146 OR 1.47 (1.11-1.93)). The risk alleles of TCF7L2 indicated impaired beta-cell function in patients and control subjects. The population attributable risks for diabetes with TCF7L2 risk alleles were 15 % and with diabetes in a first-degree relative 31 %.
The risk alleles of the TCF7L2 gene (rs12255372 and rs7903146) were strongly associated with type 2 diabetes, even after controlling for traditional risk factors in both a cross-sectional and prospective setting. These risk alleles were associated with indices of reduced beta-cell function.
在挪威北特伦德拉格郡一项基于人群的大型研究(HUNT)中,我们采用横断面研究和前瞻性设计,研究了2型糖尿病的遗传和传统风险因素的影响。
65905人参与了HUNT研究。我们研究了一组随机抽取的869名自我报告患有糖尿病或非空腹血清葡萄糖≥11.1 mmol/L的个体,以及2080名非空腹血清葡萄糖<5.5 mmol/L的非糖尿病对照个体。研究了三个基因TCF7L2(rs12255372和rs7903146)、PPARG(rs1801282)、KCNJ11(rs5219)中的四个候选多态性以及传统风险因素。
即使在横断面和前瞻性研究中对传统糖尿病风险因素(家族糖尿病史、腰围、身体活动、体重指数、收缩压以及总胆固醇和高密度脂蛋白胆固醇)进行控制后,TCF7L2基因的风险等位基因仍显示出糖尿病风险增加(横断面研究:rs12255372比值比1.61(1.31 - 1.99),rs7903146比值比1.48(1.20 - 1.83);前瞻性研究:rs12255372比值比1.59(1.22 - 2.07),rs7903146比值比1.47(1.11 - 1.93))。TCF7L2基因的风险等位基因表明患者和对照个体的β细胞功能受损。携带TCF7L2风险等位基因的人群归因风险为15%,一级亲属患有糖尿病的人群归因风险为31%。
即使在横断面和前瞻性研究中对传统风险因素进行控制后,TCF7L2基因(rs12255372和rs7903146)的风险等位基因仍与2型糖尿病密切相关。这些风险等位基因与β细胞功能降低的指标相关。